Furthermore, when we compared the TGF-β protein levels in plasma of breast cancer patients to healthy controls, the TGF-β levels was found to be dramatically upregulated in TNBC patients and Her2+ve patients (Figure 2). The gene discussed is ERBB2; the disease is breast carcinoma.